Comprehensive Case Management for Chronic Non-Cancer Pain: A Biopsychosocial Approach

The episode, part of a continuing education webinar, focuses on comprehensive case management for chronic non-cancer pain (CNCP), emphasizing its definition, prevalence, and significant impact. Dr. Snipes challenges the historical and damaging view of pain without an apparent cause as purely psychopathological, arguing that such an approach erodes the therapeutic relationship through mutual distrust and demoralizes patients. Instead, she highlights that many medically unexplained pains, like fibromyalgia, are now understood to involve complex interactions between peripheral and central neurophysiological mechanisms. A core argument is the necessity of taking patients' pain reports seriously, especially given the high comorbidity rates of CNCP with mental health issues and addiction, which are often overlooked or misattributed to drug-seeking behavior. The discussion delves into key distinctions and nuances, noting that chronic pain often follows a long, fluctuating course, requiring management rather than a definitive "cure." It draws a compelling parallel between physical and social pain (e.g., rejection, loss), revealing that both share similar neurochemical and neural substrates, underscoring the profound link between emotional and physical experiences. Brain scan studies on chronic pain patients show a shift in activity from sensory processing regions to areas encoding emotional and motivational states, suggesting that mitigating emotional and cognitive responses can significantly reduce perceived pain. The episode also provides a nuanced perspective on CBD oil, acknowledging its potential benefits for pain and mood but cautioning about the lack of regulation, variable active constituent dosages, and critical drug interactions, particularly the risk of serotonin syndrome when combined with SSRIs or opioids, which necessitates medical supervision. Practical insights and recommendations for clinicians are central to the episode. It advocates for a comprehensive biopsychosocial case management approach, recognizing the crucial role of family support in outpatient care. Clinicians are advised against automatically labeling pain patients as "drug-seeking," noting that only about 32% of pain patients have co-occurring addictive disorders. Effective pain management strategies include stress reduction to regulate the HPA axis, which can increase pain thresholds by influencing serotonin levels. The importance of a thorough pain assessment is highlighted, covering onset, quality, severity, functional impairment, emotional changes, and any pre-existing mental health, trauma, or addiction issues. Furthermore, clinicians should help patients brainstorm modifications for beloved activities to maintain engagement and self-esteem despite physical limitations. The broader implications underscore chronic pain as a pervasive public health challenge, affecting over 56% of adults and disturbingly, 11-38% of children. Its systemic impact extends beyond physical discomfort, disrupting sleep, mood, mobility, relationships, and financial stability. The neurobiological context reveals shared physiological patterns between mood, addiction, and pain, including increased systemic inflammation, altered neurotransmitter levels (dopamine, serotonin, norepinephrine), and a hyperactive HPA axis. The heightened suicide risk among young people with comorbid depression and chronic pain is a critical concern, emphasizing the need for developmentally appropriate interventions that consider the incomplete prefrontal cortex development in youth. Ultimately, the episode advocates for an empathetic, integrated, and holistic approach to chronic pain management that addresses the full spectrum of patient needs, fostering trust and empowering self-management.

"Historically pain without an apparent cause was labeled as psychopathological or all in your head."

"This approach is damaging to the patient and provider alike because it pollutes the therapeutic relationship by introducing an element of mutual distrust."

"Many medically unexplained pains are now understood to involved an interplay between peripheral and central neuro physiological mechanisms that have gone awry."

"If we don't take our patients reports of pain seriously we may be unintentionally disrupting the therapeutic relationship and I know working in addictions for you know almost 20 years a lot of patients with addictions also have chronic pain."

"About 32 percent of pain patients have addictive disorders that's important to remember because that means one-third of people that are going to the pain clinics actually do have some underlying addiction."

"Across chronic pain conditions there's generally a shift away from brain regions engaged in processing the sensory component of pain toward regions that encode emotional and motivational subjective states."

"Experiences of physical and social pain and they defined social pain as rejection exclusion bullying negative social evaluation or loss of a close relationship so social problems experiences of both physical and social pain share neurochemical and neural substrates."

"Young people with comorbid depression and chronic pain are at an increased risk of suicide."

"Effective pain management in patients with comorbid issues must address all conditions simultaneously."

"CBD oil can interact with other things like medications SSRIs somebody may be taking which can cause serotonin syndrome."